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Abstract
Mounting evidence implicates axonal transport defects, typified by the presence of axonal
varicosities with aberrant accumulations of cargo, as an early event in Alzheimer’s disease (AD)
pathogenesis. Work identifying amyloid precursor protein (APP) as a vesicular motor receptor for
anterograde axonal transport further implicates axonal transport in AD. Manganese-enhanced MRI
(MEMRI) detects axonal transport dynamics in preclinical studies. Here we pursue an
understanding of the role of APP in axonal transport in the central nervous system by applying
MEMRI to hippocampal circuitry and to the visual pathway in living mice homozygous for either
wild type or a deletion in the APP gene (n = 12 for each genotype). Following intra-ocular or
stereotaxic hippocampal injection, we performed time-lapse MRI to detect Mn2+ transport. Three
dimensional whole brain datasets were compared on a voxel-wise basis using within-group pair-
wise analysis. Quantification of transport to structures connected to injection sites via axonal fiber
tracts was also performed. Histology confirmed consistent placement of hippocampal injections
and no observable difference in glial-response to the injections. APP −/− mice had significantly
reduced transport from the hippocampus to the septal nuclei and amygdala after 7 hours and
reduced transport to the contralateral hippocampus after 25 hours; axonal transport deficits in the
APP −/− animals were also identified in the visual pathway. These data support a system-wide
role for APP in axonal transport within the central nervous system and demonstrate the power of
MEMRI for assessing neuronal circuitry involved in memory and learning.
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Introduction
Alzheimer’s disease (AD) is characterized by progressive neuronal and synaptic dysfunction
and loss. Progressive deficits in episodic memory ultimately lead to marked dementia,
evidenced by loss of short-term memory, impaired judgement, altered behaviour, and
general decline in cognitive function (Keller, 2006). The pathological hallmarks of AD are
senile plaques and neurofibrillary tangles (NFTs); both of which involve proteins implicated
in axonal transport. Mounting evidence implicates axonal transport defects, typified by the
presence of axonal varicosities with aberrant accumulations of cargo, as an early event in
AD pathogenesis (Stokin et al., 2005).
Senile plaques are lesions comprised of a core of aggregated amyloid-β (Aβ) surrounded by
reactive astrocytes, dystrophic neurites and activated microglia (Ishihara et al., 1991). Aβ,
the main constituent of senile plaques, is derived from the proteolytic cleavage of the
amyloid precursor protein (APP), a type I, 695 – 770 residue, glycosylated transmembrane
protein with a large hydrophilic extracellular domain, a hydrophobic 23 residue
transmembrane domain and a short, 47 residue, cytoplasmic domain (Walsh and Selkoe,
2007). The normal physiological role of APP is unclear but several functions have been
proposed, including roles in axonal transport, cell adhesion, copper homeostasis and
neuronal migration during development (Heber et al., 2000; Herms et al., 2004; Kamal et al.,
2001; Muller et al., 1994; Satpute-Krishnan et al., 2006; Young-Pearse et al., 2007). Studies
in APP knock-out mice (APP−/−) also identify impaired hippocampal long-term
potentiation (LTP) and deficits in passive avoidance learning (Dawson et al., 1999; Senechal
et al., 2008).
The identification of APP as a vesicular motor receptor for anterograde axonal transport
machinery links axonal transport to the senile plaques observed in AD. Various transgenic
animal models have proven valuable for discovery of this physiological role of APP (Price
et al., 2000). For example, deletion of the Drosophila homolog of APP results in
anterograde transport defects similar to those produced by a kinesin light chain (KLC)
knock-out (Gunawardena and Goldstein, 2001; Torroja et al., 1999). Similarly, deletion of
APP in mice results in a reduction in anterograde transport of kinesin-1 cargo (Kamal et al.,
2001), possibly mediated by binding of the cytoplasmic domain of APP to kinesin-1 light
chains (Kamal et al., 2000); whether transport is mediated through direct binding between
APP and KLC remains controversial (Lazarov et al., 2005). Subsequently, a short peptide
sequence (15 aa) derived from the cytoplasmic C-terminus of APP was found to be
sufficient for anterograde transport of exogenous cargo in the giant axon of the squid
(Satpute-Krishnan et al., 2006). More recent work reported the travel of endogenous APP
cleavage products to specific cellular destinations and noted this segregation was abolished
upon APP overexpression, indicating an increasingly complex system (Muresan et al.,
2009). Histological evidence indicative of defective axonal transport has also been reported
in a variety of mouse models of AD that over-express mutant forms of APP, Presenilin-1
and/or tau (Stokin et al., 2005; Wirths et al., 2006). Taken together these observations
suggest APP and its metabolites are connected to axonal transport mechanisms and that
manipulation of APP would lead to axonal transport deficits (Shah et al., 2009).
Manganese-enhanced magnetic resonance imaging (MEMRI) enables in vivo assessment of
axonal transport due to three properties of Mn2+: its paramagnetism leads to alterations in T1
relaxation time, producing a hyper-intense signal in T1-weighted MR images; as a calcium-
analogue Mn2+ enters neurons via calcium channels; and, once inside neurons, Mn2+ is
transported via fast axonal transport (Bearer et al., 2009; Lin and Koretsky, 1997; Merritt et
al., 1989; Pautler, 2004; Silva et al., 2004; Zhang et al., 2010). MEMRI protocols detecting
axonal transport have identified deficits in aged rats (Cross et al., 2008) and in mouse
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models of AD (Kim et al., 2011; Smith et al., 2007; Smith et al., 2011). In vivo assessment
has predominantly focused on axonal transport in the fascicles of the olfactory bulbs and
recent work identified a deficit in olfactory bulb axonal transport in APP −/− mice (Smith et
al., 2010). Bearer and colleagues, 2007, identified a dependence for Mn2+ transport on
kinesin light chain 1, a subunit of the kinesin-1 motor protein (Bearer et al., 2007a). Thus
Mn2+ transport detected by time-lapse MRI is a reliable biomarker for microtubule-based
axonal transport within the living brain.
Here, we exploit MEMRI to assess axonal transport dynamics between the hippocampus and
other brain regions - the septal nuclei of the basal forebrain, amygdala, and contralateral
hippocampus - in mice with and without the APP gene; and in separate experiments we also
assess axonal transport dynamics in the visual pathway from retina to brain. Successive MR
images of the same animal acquired over time after Mn2+ injection allow us to follow Mn2+-
induced hyperintensity progressing along well-established fiber tracts composed of axonal
bundles. After rigorous investigation of injection site locations and possible confounding
factors due to APP absence, such as microglial activation and volumetric alterations in APP
−/− mouse brains, statistical parametric analysis revealed deficits in axonal transport in the
central nervous system of APP−/− animals.
Methods
Animals
Mice were obtained from Jackson Laboratories (Stock number 004133, Bar Harbor, ME), 12
female APP −/− and 12 wild type controls hereafter referred to as APP −/− and wild type
respectively, were used in this study. APP −/− mice were designed on a C57BL/6J
background lacking the promoter and first exon of APP as previously described (Zheng et
al., 1995) and as used in a study identifying transport deficits in the olfactory system via
MEMRI (Smith et al., 2010). Animals were between 4 – 5 months of age at the time of
experiments and genotypes were confirmed by PCR at JAX according to their standard
protocols. APP−/− mice were smaller than wild type and this finding extended to the brain.
However, structural abnormalities in the hippocampal commissures reported for other strains
of APP deficient mice (Magara et al., 1999) were not present in the strain used in this study
(Supplemental Fig. 1a,b). All protocols involving animals in this work were approved by
both the Institutional Animal Care and Use Committee (IACUC) of the California Institute
of Technology and the University of New Mexico IACUC committee.
Intra-ocular Manganese Injections
Mice were anesthetized using 1.5 % isoflurane, placed into a stereotaxic frame (Kopf
Instruments, CA, USA) and maintained under anesthesia throughout intra-ocular Mn2+
administration. A fine steel needle (30 gauge, 0.3 mm) was used to bore into the sclera.
Upon removal of the needle, a catheter tip (Tail-vein catheter, SAI Inc., IL, USA) was
introduced into the eye. Mn2+ (250 nl, 200 mM; prepared with deionized water in sterile
saline) was injected behind the lens into the vitreous of the right eye over the course of a
minute, the catheter was slowly removed and the animal transferred to the MR scanner and
maintained under anesthesia with 1 – 1.5 % isoflurane in medical grade air during a scan to
confirm Mn2+ presence in the eyeball (Bearer et al., 2007a). Animal respiration and chamber
temperature were monitored during scanning.
Stereotaxic Hippocampal Injections
The stereotaxic injection procedure was similar to that employed by Bearer et al, 2007
(Bearer et al., 2007b). Briefly 5 nl of 500 mM Mn2+, prepared with deionized water, was
injected unilaterally into the right hippocampus (coordinates x = −3.2 mm (midline), y =
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−4.1 mm (bregma), z =3.4 mm (down) (Paxinos, 2001)) over 5 minutes using a quartz
micropipette guided by computer-assisted stereotaxic injector (myNeuroLab.com, IL, USA).
All mice also received 0.5 mg/ml rhodamine dextran-amine (RDA; 3k; Molecular Probes/
Invitrogen, OR, USA) during Mn2+ administration. Following micropipette removal,
animals were transferred to the scanner and maintained under anesthesia with 1 – 1.5 %
isoflurane in medical grade air. Inspection of MR images obtained 1 hour after injection
enabled identification of a hypointense region representing the injection site. The
coordinates of this region were identified in all animals and translated to the bregma
coordinate system by applying the transformation required to align the coordinates of the
anterior commissure in the 1 hour MR images and the high resolution template image used
throughout the study.
Magnetic Resonance Imaging
All animals were imaged prior to administration of Mn2+ to acquire a pre-injection image.
Mice received 0.3 ml of saline subcutaneously before each imaging session and protective
eye ointment was applied to protect eyes from damage (Puralube, Pharmaderm, NY).
Animals receiving hippocampal injections were imaged at 0:54 ± 0:15, 6:41 ± 0:11 and
24:43 ± 0:23 hours post injection. Animals receiving intra-ocular injections were imaged 1
hour after injection to check that the injection was successful; the increased T1 weighted
signal intensity confirmed the presence of Mn2+ in the globe. These animals were then
returned to their cages and imaged 25:14 ± 0:45 hours later. No significant differences
existed in the times for experimental groups. The midpoint of each 46 minute scan was
identified as the “scan time” and in the case of the hippocampal injections will be referred to
as occurring 1, 7, and 25 hours after Mn2+ injection. Imaging following intra-ocular
injection will be referred to as 25 hours after injection. Both procedures were performed on
the same group of mice, with intra-ocular experiments performed at minimum 14 days prior
to the hippocampal experiments in all instances. Previous experimental observations from
this laboratory indicated this was sufficient to ensure Mn2+ clearance (Zhang and Jacobs,
unpublished observations). Further validation that this wait time eliminated contaminating
intensities from the eye injection is evidenced by the absence of signal increase in visual
pathways in the hippocampal injection analyses.
An 11.7 T 89 mm vertical bore Bruker BioSpin Avance DRX500 scanner (Bruker BioSpin
Inc., Billerica, MA) equipped with a Micro 2.5 gradient system was used to acquire all
mouse brain images with a 35 mm linear birdcage radio frequency (RF) coil. During
imaging the animal's head was secured in a Teflon stereotaxic unit within the RF coil to
minimize movement and to aid in reproducible placement. Temperature and respiration were
continuously monitored during data acquisition and remained within normal ranges. Similar
to previous MEMRI studies carried out by this group (Hennig et al., 1986), we employed a
3D RARE imaging sequence with RARE factor of 4 and the following parameters: 4
averages, TR/TEeff = 250 ms/12 ms; matrix size of 160×128×88; FOV 16 mm × 12.8 mm ×
8.8 mm; yielding 100 µm isotropic voxels with a 46 minute scan time.
Fixation for Histology and Diffusion Tensor Imaging
Mice were sacrificed 9 – 10 days after the final MR imaging session. Each mouse was
anaesthetized and perfused with warm heparinized phosphate buffered saline (PBS; 30 ml)
followed by 30 ml of room temperature 4 % paraformaldehyde (PFA) in PBS. Following
decapitation the head was rocked in 4 % PFA in PBS overnight at 4 °C. Samples intended
for ex vivo MRI were kept within the skull, had all skin and cartilaginous tissue removed and
were maintained at 4 °C in 0.01 % sodium azide in PBS before further processing prior to
scanning.
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Diffusion-Weighted MRI
Two intact heads prepared as described above were secured in a Teflon® holder and
submerged in perfluoropolyether (Fomblin®, Solvay Solexis, Inc., Thorofare, NJ) within a
50 ml vial and imaged at 4°C. Diffusion weighted images (DWI) were acquired using a
conventional pulsed-gradient spin echo (PGSE) sequence (TR/TE = 300 ms/11.9 ms,
256×150×120 matrix, 25.6 mm ×15 mm ×12 mm FOV, 100 µm isotropic voxel size, 1
average, δ = 3 ms, Δ = 5.2 ms, Gd = 1125 mT/m, nominal b-factor = 3370 s/mm2). An
optimized six point icosahedral encoding scheme (Hasan et al., 2001) was used for diffusion
weighted acquisitions with a single un-weighted reference image for a total imaging time of
14.5 hours. Fractional Anisotropy (FA) maps were calculated and regions of interest (ROI)
were manually drawn on the dorsal hippocampal commissure and corpus callosum
(combined) and the ventral hippocampal commissure to determine an average fractional
anisotropy (FA) for both groups. Results are presented in Supplementary Fig. 1a.
Histology
Histological examination was performed on 8 brains, 4 APP −/− and 4 wild type. Prior to
processing, each brain was released from the skull, post-fixed for 1 – 3 days and sent to
Neuroscience Associates (NSA, TN, USA) for gelatin embedding and frozen sectioning as
described (Bearer et al., 2009). Brains were embedded in a single gelatin block and
sectioned in register at 30 µm thickness. Every 12th section was stained with a Solochrome
technique, developed for this study in collaboration with NSA, and an adjacent section
mounted in DAPI-containing anti-quench and mounted for fluorescence microscopy of the
co-injected rhodamine-dextran. Microglial activation was assessed by inspection of sections
stained by indirect immunohistochemistry for ionized calcium binding adaptor molecule 1
(Iba1). Cholinergic neurons were detected by immunohistochemistry for choline
acetyltransferase (ChAT) (Bearer et al., 2007b). Microscopy of whole brain sections was
performed using a Zeiss V8 stereoscope equipped with an Axiocam running AxioVision 4.8,
bright and dark-field illumination and three fluorescent filter cubes for DAPI, TRITC, and
FITC. High magnification assessment of rhodamine-dextran and DAPI at the injection site,
the septal nuclei in the forebrain and the contralateral hippocampus were obtained on a Zeiss
Axioscope Z1 with an MRM and HRC Axiocam running AxioVision 4.6 software.
Microscopy images were prepared for publication figures using Adobe Photoshop.
MR Image Alignment and Pre-Processing
MR images were skull-stripped using the Brain Surface Extractor within BrainSuite9
(Shattuck and Leahy, 2001) and the Extract Brain Surface tool in MIPAV (Biomedical
Research and Services Section, 2011). Inaccuracies were corrected by manual revision of
the masks in either image processing tool. Statistical parametric mapping (SPM) analysis
was completed in a similar fashion to previous MEMRI studies published by our group
(Bearer et al., 2007b; Bearer et al., 2009; Zhang et al., 2010). Briefly, after skull-stripping,
each image was scaled to the mode of its intensity histogram. A high-resolution in vivo MR
image of a wild type mouse (80 µm isotropic; 145×180×88 matrix; RARE) obtained 24
hours following intraperitoneal administration of Mn2+ (0.4 mM/kg in 0.4 ml saline),
providing excellent contrast of brain structures normally unidentifiable (Aoki et al., 2004),
was utilized as the template image in this study; such that all images acquired in this study
were co-registered to this image as described below. With reference to the Paxinos and
Watson Mouse Brain Atlas (Paxinos, 2001), brain regions identifiable and relevant to this
study (e.g. hippocampus, superior colliculus) were segmented on this template image;
enabling visualization of injection sites and SPM results with respect to relevant brain
regions. The segmented anatomical regions were also used to identify the number of
statistically significant voxels in specific anatomical regions.
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All pre-injection images obtained in this study were registered to the template image using a
12-parameter full-affine model. The resulting transformation was used as input for the
transformation of the post-injection images to the template using Alignlinear, following
initial linear alignment (12 parameter model) using the LONI Pipeline Processing
Environment (Rex et al., 2003). Group-specific average images were created to enable
visual assessment of signal enhancement due to Mn2+ presence and transport following
intra-hippocampal and intra-ocular Mn2+ administration. Final images were prepared for
SPM analysis through application of 0.3 mm Gaussian kernel.
Statistical Parametric Mapping
We interpret Mn2+-induced hyperintensity distant to the injection site at time-points later
than the time of injection to be indicative of axonal transport when these sites are connected
to the injection site by well-established axonal fiber tracts. For example, Mn2+ intensities
tracing along the hippocampal fimbria and fornix to the septal nuclei of the basal forebrain,
or along the hippocampal commissure to the contralateral hippocampus meets this
definition.
A wide range of axonal transport rates for Mn2+ (Bearer et al., 2007a), in addition to other
tracers, are reported in the literature (Satpute-Krishnan et al., 2006); suggesting a ‘leading
edge’ of Mn2+ transport may be present in fiber tracts connected to the injection site. Direct
comparisons between time-points (e.g. 7 hours versus 1 hour) do not take into account the
potentially confounding effects of such a ‘leading edge’, should it be below a chosen
statistical significance in the direct comparison. Consider a location with a Mn2+ induced
signal increase at time-point 1. To achieve statistical significance in a direct comparison at
time-point 2, a greater Mn2+-induced signal increase is required at this location compared
with locations that did not have a Mn2+-induced signal increase at time-point 1. Thus a
leading edge of Mn2+ transport can undermine direct time-point comparisons.
In the hippocampal injection analysis, we generate three composite time-point comparisons
using combinations of direct time-point comparisons. (1) Increase after injection,
comparison of 1 hour and pre-injection images (see Supplemental Fig. 1c); (2) Increase at 7
hours, comparison of 7 hours and pre-injection images (see Fig. 3); and (3) Increase at 25
hours, comparison of 25 hours and pre-injection images (see Fig. 4b, 5b). A voxel
significant in Comparison (1) can only be significant in Comparison (2) if identified as
statistically significant in a direct comparison of 7 hour and 1 hour images. Similarly, voxels
significant in Comparison (2) can only be significant in Comparison (3) if identified as
statistically significant in a direct comparison of 25 hour and 7 hour images. Images
obtained 25 hours after intra-ocular injections were compared to pre-injection images (see
Fig. 7). All comparisons were performed in SPM8 using intragroup paired Student’s t-test
and significance was considered reached at p < 0.00001, corresponding to a T-value greater
than 7.09 (n = 12 in all groups).
This analysis method generated maps used to assess inter-group differences by: (1) Visual
assessment of the extent of the increases along pathways, at the same time-point; (2) Visual
assessment of the time-point at which increases were observed at specific anatomical
locations; (3) Numerical assessment of the extent of the increases at specific anatomical
locations along a pathway. The segmentation of anatomical structures of interest (e.g.
hippocampus, septal nuclei) on the high resolution in vivo template used in this study
enabled non-biased numerical assessment to take place (see Table 1).
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Tensor-based morphometry
A deformation field analysis implemented by Thompson and coworkers (Thompson et al.,
2008) was used to analyze whether MRI brain scans of the APP −/− were different from
wild type mouse brain scans; processing was implemented in the LONI Pipeline Processing
Environment (Rex et al., 2003). Briefly, all pre-injections scans were mapped into a wild
type minimum deformation template (MDT) and the resulting displacement field (JTJ, with J
the deformation Jacobian) for each scan determined. An Independent samples t-test
assessing the difference between the absolute value of the determinants of the displacement
fields of the wild type and APP −/− scans identified areas of significant changes in the APP
−/− brains. Results are presented in Supplementary Fig. 1b at a significance level of p <
0.00001 corresponding to a T-value greater than 7.09 (n = 12). Visualization of the MR
images and SPM was performed with Amira (Visage Imaging, San Diego, CA) and MRIcro
(Rorden and Brett, 2000).
Results
Injection site location and tissue status are similar in wild type and APP −/− mice
MR images of individual skull-stripped brains and the averaged dataset for all 12 brains for
each genotype reveal consistent placement of the injection site in the hippocampus (Fig. 1a).
Note that the averaged image preserves anatomical details detected in the image for a single
individual, validating alignments and demonstrating the precision of injection location.
Injection sites appear as focal areas of hypointensity within a bright hyperintense halo in
MR images taken 1 hour post Mn2+ administration (Fig 1a; arrows) due to Mn2+ varying
effects on relaxation times at different concentrations. The average injection sites were
identified as x = −3.2 ± 0.28 mm, y = −4.66 ± 0.42 mm and z = −3.60 ± 0.50 and x = −3.17
± 0.32 mm, y = −4.76 ± 0.31 mm and z = −3.80 ± 0.43 for wild type and APP −/− mice
respectively (n = 12); no significant differences between groups were detected. Injection
sites, represented as spheres, overlaid onto coronal, axial and sagittal semi-transparent
volumes of the template image illustrate the accuracy of injection placement (Fig 1b; wild
type, blue; APP −/−, red).
Our previous work identified minimal glial response following intra-hippocampal Mn2+
administration at the volume (5 nl) and concentration (500 mM) used in this study (Bearer et
al., 2007b). However, reactive gliosis is a known phenotype of APP −/− mice (Dawson et
al., 1999; Zheng et al., 1995); as such it is reasonable to anticipate that APP −/− mice may
display an exacerbated inflammatory response following injection. Brain sections prepared
from the mice used in this study were assessed for microglial activation (Iba1). No
differences between the groups at the injection site were observed (Fig. 1c, d); the injection
site appears as a small cavity. Fluorescence microscopy demonstrated rhodamine-dextran
fluorescence in an injection site within the hippocampal CA3 subfield of a brain section
from an APP −/− mouse (Fig. 1e).
A lower body weight was recorded for APP −/−, compared with wild type, mice (data not
shown). Skull-stripped pre-injection images were used to assess the overall brain volume of
wild type and APP −/− mice and were consistent with previous reports of this strain of APP
−/− mice having reduced brain size (Zheng et al., 1995) (Supplementary Fig. 1a; ** P <
0.01; Students t-test for independent means). To ensure that areas under investigation in this
study were not unduly reduced, tensor-based morphometric (TBM) analysis was performed
using the pre-injection images (Supplementary Fig. 1b). The olfactory bulbs, dorsal tenia
tecta, thalamus, subiculum and cerebellum were identified as being smaller in APP −/−
compared with wild type mice. Importantly, no differences were observed in the
hippocampal-forebrain neural circuitry and hippocampal commissures.
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Previous neuroanatomical studies of APP −/− strains different from the mice used in this
study have reported occurrences of callosal agenesis and hippocampal commissure defects
in mice exclusively derived from the 129/SvEv background (Magara et al., 1999). These
mice were generated by a 200 kilobase deletion of the APP gene and backcrossed onto either
the C57BL/6J or 129/SvEv strain; both showed reductions in brain size. The APP −/− mice
used in this study were backcrossed onto the C57BL/6J strain and pre-injection APP −/−
images were assessed for corpus callosum presence and no incidences of callosal agenesis or
Probst bundle formation were observed (Muller et al., 1994). To assess hippocampal
commissure viability, a subset of APP −/− (n = 4) and wild type (n = 2) brains were scanned
ex vivo overnight using diffusion tensor imaging (DTI). No differences in fractional
anisotropy, a measure of tract integrity of the hippocampal commissures, were observed
between groups (Supplementary Fig. 1a). Visual assessment of hippocampal commissures in
brain sections, prepared from wild type and APP −/− mice, stained for myelin with a
modified solochrome technique that accentuates fiber tracks, identified no major
commissure defects (after adjusting for brain size) (Supplementary Fig. 2a).
The hyperintense region, encircling the injection site, visible on representative 1 hr images
in Fig. 1a indicates passive Mn2+ diffusion from the injection site and is commonly found in
MEMRI images involving localized intra-cerebral administration (Bearer et al., 2007b;
Bearer et al., 2009). Previous studies noting similar patterns record no lack of specificity in
subsequently identified projection patterns (Allegrini and Wiessner, 2003; Pautler et al.,
2003; Pautler et al., 1998a; Saleem et al., 2002; Van der Linden et al., 2002). The
statistically significant signal increases due to Mn2+ administration at the 1 hour time-point
were assessed by paired Students t-test comparisons of the 1 hour and pre-injection skull-
stripped and co-registered whole brain images; volumes of 0.93 mm3 and 0.84 mm3 were
increased in the wild type and APP −/− injection site hippocampi respectively (performed
on SPM output calculated to p < 0.00001, T = 7.09, n = 12; Supplementary Fig. 1c, Table 1),
demonstrating a consistent reproducible amount of Mn2+ had been injected in the two
cohorts.
Hippocampal-forebrain axonal transport of Mn2+ is reduced in APP −/− mice
Mn2+ injected into CA3 of the hippocampus transports along the hippocampal fimbria,
down the fornix and arrives in the septal nuclei of the basal forebrain within 6 hours in wild
type mice (Bearer et al., 2007b). Segmentation of the hippocampal formation and the septal
nuclei illustrate the start- and endpoint structures involved in this transport (Fig. 2a).
Coronal MR slices from a representative wildtype mouse, at the 7 hour time-point,
demonstrate Mn2+-induced signal intensity at these structures; ipsilateral signal increase in
the hippocampal formation (slice positioned at approximately bregma – 3.8 mm) and at the
septal nuclei (slice positioned at approximately bregma + 0.4 mm). These signal changes
due to axonal transport of Mn2+ are observable in axial slices of individual mice from each
genotype, and group averages (Fig 2b).
A representative fluorescence micrograph from an APP −/− mouse demonstrates transport
of the rhodamine-dextran to the appropriate location, confirming that the injection
introduced tracer into the expected circuit originating in the hippocampus (Fig. 2d). No
qualitative differences in numbers, size, or location of cholinergic neurons, as detected by
ChAT staining, was found in the medial septal nuclei of APP−/− compared to wild type
mice (Fig. 2d,e respectively). No significant difference in numbers of Iba1 stained cells, a
marker of glial activation, was found between genotypes (Supplementary Materials, Fig.
2b).
Voxelwise SPM of the Mn2+-induced signal increase at 7 hours indicates both groups
transport Mn2+ along the hippocampal-forebrain pathway (Fig. 3). Overlay of SPM maps
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onto slices from the template image enables visual assessment of underlying structures,
particularly the dorsal hippocampal commissure, ventral hippocampal commissure and
septal nuclei. Significant voxels in the wild type extend further forward and occupy a greater
volume of the septal nuclei; 0.39 mm3 (17% of septal volume) in wild type compared with
0.11 mm3 (5% of septal volume) in APP−/− (Table 1). Increases detected in the amygdala in
wild type at the 7 hour time-point were not observed in APP −/− mice until the 25 hour
time-point, and were reduced in volume (Supplemental Fig. 3, Table 1).
Contralateral Mn2+ transport is reduced in APP −/− mice
Images taken 25 hours after Mn2+ administration demonstrate new signal increases in the
contralateral hippocampus, the ipsilateral thalamus, and further anterior along the
hippocampal-forebrain circuit in wild type mice (Fig. 4a). Mn2+ signal also continues to
increase in the septal nuclei. By SPM analysis and comparison to mouse atlases, increases
along the hippocampus to forebrain connections extend into the dorsal tenia tecta and
nucleus accumbens in both groups, reaching the infralimbic cortex in wild type. Similar to
the 7 hour time-point, statistically significant signal appeared further rostral and occupied
greater volumes in wild type than in APP −/− mice (Fig. 4b).
Rhodamine-dextran fluorescence appears in the contralateral hippocampus in brain sections
prepared from wild type and APP −/− mice (Fig. 5a,b); fluorescence was sharply restricted
to the CA2 and CA3 pyramidal layer (white arrowheads) and reduced in APP −/− compared
with wild type sections. Visual assessment indicated contralateral Mn2+ transport to be
greater in wild type, compared with APP −/−, mice (Fig 4b). The increase exclusive to the
hippocampal formations are presented within semi-transparent renderings of the
hippocampal structure for wildtype and APP −/− groups (Fig. 5c); quantification indicated
24% (3.02 mm3) of the contralateral hippocampus was increased in wildtype mice, while
coverage of only 2% (0.25 mm3) was observed in APP −/− mice (Fig. 5c, Table 1).
Reduced Mn2+ transport in the visual pathway of APP −/− mice
Mn2+ enters retinal ganglion cells and travels within their axons in the anterograde direction
along the optic nerve to the midbrain where retinal axons terminate in the superior colliculus
and lateral geniculate nucleus (Bearer et al., 2007a; Watanabe et al., 2001)(diagrammed in
Fig 6a). A coronal MR slice from a representative wild type mouse (approx. −3.8 mm
bregma) taken 25 hours after intra-ocular administration, of 0.25 µl of 250 mM Mn2+,
illustrates signal enhancement at the superior colliculus (Fig. 6a). At 25 hours after intra-
ocular administration, Mn2+-induced signal is visible in the superior colliculus in single
images of both wild type and APP−/− individuals, and clear in the averaged images of all 12
animals in both groups (Fig. 6b,c).
SPM analysis reveals intensity increases at the lateral geniculate nucleus and superior
colliculus (Fig. 7). In the wild type, Mn2+-induced intensity increases were consistently
greater in extent when compared with APP −/−. Quantification of the increases in the lateral
geniculate nucleus and superior colliculus identified increases of 0.43 mm3 (26 % coverage)
and 1.81 mm3 (16 % coverage) in wild type respectively, while in APP −/− mice increases
were much less, only 0.28 mm3 (17 % coverage) and 0.90 mm3 (6 % coverage) respectively.
Discussion
MEMRI examination of the visual pathway and hippocampal-based circuits, provided the
same conclusion: axonal transport is reduced in mice knocked out for the APP gene. We
identified reduced Mn2+ axonal transport along the fiber tracts from hippocampus to the
amygdala and basal forebrain at 7 hours after Mn2+ administration, and a reduction in both
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rostral and contralateral transport at 25 hours in APP−/− mice. Of special note was a
decrease in transport across the midline to the contralateral hippocampus, detected both in
the MEMRI image analysis and with co-injected traditional tract tracer, low molecular
weight rhodamine-dextran, by histology. This additional detail arises in part from our ability
to deliver a small volume of tracer to a precise hippocampal location and also from our large
dataset which allowed stringent statistical analysis. In separate experiments a reduction in
Mn2+ transport in the visual pathway from eye to midbrain and superior colliculus was also
observed after intra-ocular administration in APP−/− animals. This result demonstrates a
specific role for APP in anterograde transport of Mn2+.
This study supports a critical role for APP in transport, and demonstrates that transport
dynamics are witnessed by MEMRI. It is worth noting that the axonal transport reduction
detected here occurred in the presence of APP homologues: APLP1 and APLP2 (Heber et
al., 2000). These homologues may rescue some of the deficits incurred by the loss of APP,
but do not return transport to normal. Similarly, MEMRI identified axonal transport
impairments in mice deficient for kinesin-1 light chain (Bearer et al., 2007a) even though
there are two other kinesin-1 light chains and several other of the 45 kinesins in the mouse
genome are also likely to mediate axonal transport (Hirokawa et al., 2010). Cargo receptors
for motors other than the APP family have been reported, such as Jun-interacting proteins
(JIP) 1, 2 (Verhey et al., 2001) and JIP 3 (Bowman et al., 2000) and even negatively charged
membrane lipids (Klopfenstein et al., 2002). Thus transport is reduced, but not abolished, in
mice knocked out for a single component of the redundant and multi-component axonal
transport machinery. Whether these multiple components play specialized roles in specific
pathways remains unknown. The degree of impairment reported here suggests that APP may
be one of the more important components for inter-hippocampal communications not
previously recognized. Typically only major differences in transport can be detected using
histologic tracers. That we detect a difference here indicates a major defect in inter-
hippocampal transport in these APP−/− mice. Such precise mirroring of connections
between right and left hippocampal domains has not been previously reported, and is likely
due to the precision of placement and the small volume of our injection which labels only a
small subset of domain-specific neurons.
MEMRI investigation of axonal transport in hippocampal-based circuitry involves multi-
synaptic and bidirectional transport of Mn2+. Although retrograde Mn2+ transport has been
reported (Matsuda et al., 2010), the speed and extent is unknown with respect to anterograde
transport, which appears to dominate Mn2+ transport (Pautler et al., 1998b; Sloot and
Gramsbergen, 1994; Tjalve et al., 1995). MEMRI work examining axonal transport in the
hippocampal-forebrain circuit of a mouse model of Down syndrome identified a marked
increase in axonal transport (Bearer et al., 2007b). These mice have a 1.5-fold expression of
murine APP. In the APP−/− mice studied here we find the expected diminished transport
not only in the hippocampal-forebrain connection but also in hippocampal connections to
the amygdala and contralateral hippocampus and in the optic tract. The analogous deficit in
the visual-pathway reported here and effects of mutated APP overexpression and APP
absence in the olfactory circuit (Minoshima and Cross, 2008; Smith et al., 2010) suggest
axonal transport dependence on APP is not regional. Our work extends previous studies,
confirming that APP is involved in modulating axonal transport in a main learning and
memory circuit. Furthermore, APP overexpression disrupts hippocampal-based retrograde
transport of nerve growth factor (NGF) to basal forebrain cholinergic neurons, leading to
neuron degeneration (Salehi et al., 2006) suggesting APP manipulation can lead to bi-
directional transport deficits.
Previous studies have identified an age-related reduction in axonal transport in the olfactory
bulbs of rats and mice (Cross et al., 2008; Smith et al., 2010). Through utilization of the
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methodology presented in this study, we would expect to identify analogous axonal transport
deficits in hippocampal-based circuitry and the optic tract. However, in animal models
involving genetic manipulation of APP, it is reasonable to suggest APP-mediated alterations
to axonal transport would predominate alterations due to age. As such, examination at a
single age-point appears sufficient in consideration of APP-mediated changes to axonal
transport but studies examining the efficacy of pharmacological interventions may benefit
from consideration of the age-related changes (Smith et al., 2011). We chose to study mice
younger than 6 months old as non-specific reactive gliosis has been reported in older
animals (Zheng et al., 1995).
In addition to the axonal transport deficits due to APP loss, alterations in trans-synaptic
trafficking of Mn2+ and cellular electrophysiology may also modulate Mn2+ presence distal
to the injection site. Pre-synaptic reduction of APP and APLP2 (via siRNA) decreased
synaptic efficacy in vivo (Herard et al., 2006). While the concomitant reduction in APLP2
makes extension to APP deficient mice complex, it is reasonable to suggest that a reduction
in synaptic efficacy may also contribute to the findings in this study. Electrical activity is not
required for Mn2+ uptake but it is necessary for trans-synaptic transport of Mn2+ (Bearer et
al., 2007a). Electrophysiological assessment of APP −/− mice reported an impairment in
hippocampal LTP at 8 – 12 months of age, in addition to identifying a disruption in the pre-
synaptic marker synaptophysin (Dawson et al., 1999; Seabrook et al., 1999). However, the
mice used here are significantly younger and there are no reports of LTP impairment or
reductions in synaptic markers for young APP −/− mice. Thus the main effect of APP loss,
with respect to Mn2+ transport, in this cohort would be transport dysfunction.
Our results may also point to a biochemical cellular basis for behavioural defects described
in the APP−/− mouse. Pathway-specific alterations due to APP loss may affect Mn2+
transport because of underlying connectivity strength differences; MEMRI studies have
provided evidence that the level of functional connectivity between two separate anatomical
regions can influence the extent of axonal transport of Mn2+ (Michaelis et al., 2004; Van der
Linden et al., 2002; van der Zijden et al., 2007). Deficits in passive avoidance (Senechal et
al., 2008) and conditioned avoidance learning paradigms (Dawson et al., 1999) in APP −/−
mice at 10 months of age have been reported; these tasks are thought to involve the
hippocampus and amygdala. Indeed, we identify a reduction in axonal transport in
hippocampal-amygdala connections in APP −/− mice at 3 – 4 months of age.
APP plays an important role in memory (Dodart et al., 2000) and APP deletion,
overexpression and mutation have been found to lead to impairments in a variety of learning
paradigms (Granholm et al., 2003; Puolivali et al., 2002). Through its capacity to influence
axonal transport - either by absence, mutation or overexpression - APP could impair the
brain via failures in the delivery of a potentially wide range of molecules necessary for
learning and memory. If a correlation to Alzheimer's disease were to be made, where the
toxic fragment of APP, Aβ, induces axonal transport impairments, these impairments are
unlikely to resemble single unit deficits, such as those produced by APP loss reported here
(Stokin et al., 2005). It may be that Aβ-deposition disrupts transport in more complex ways
than the absence of a single unit of the axonal transport machinery.
Previous MEMRI work reported a deficit of Mn2+ transport in the olfactory bulbs, after
nasal delivery, in APP−/− mice (Smith et al., 2010). The primary advance in the work
presented here is a demonstration, via both MEMRI and classical tracer methods, that APP
is required for movement of Mn2+ along well established axonal fiber bundles in specific
neuronal circuits. Our study reveals a dependence on APP for transport along these bundles
in the key memory circuit from hippocampal to septal nuclei and basal forebrain. The
extension of this finding to the visual pathway and rigorous assessment of putative
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morphological changes in the circuits examined strengthen the key conclusion that APP is a
key component of transport in the central nervous system. Our studies indicate MEMRI
imaging will provide insight into the effects of Aβ on transport dynamics in subsequent
studies.
Summary
Here we demonstrate APP is required for normal axonal transport in hippocampal-based
circuitry prone to plaque deposition and implicated in many of the higher level executive
functions that undergo degeneration in AD. Replication of this finding in the visual pathway
also reported here confirms the system-wide involvement of APP in axonal transport.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Injection site location and tissue status are similar in wild type and APP −/− mice
(a) Representative and group average MR axial images before (Pre) and 1 hour (1 hr) after
intra-hippocampal Mn2+ administration are presented (scale bar = 1 mm). Visual inspection
of the Mn2+ signal enhancement identifies an initially focal pattern after 1 hour (the area of
hypointensity is used to generate injection site co-ordinates; denoted by an arrow). (b)
Injection site locations, represented as a sphere for each animal used in the statistical
analysis of hippocampal injections, confirms placement in the hippocampal CA3 subfield
for both groups (blue and red spheres correspond to wild type and APP −/− mice
respectively). Injection sites locations have been overlaid onto coronal, axial and saggital
semi-transparent rendered images of the MRI template (Scale bar = 1 mm). (c) and (d)
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Representative micrographs of Iba1 staining to assess microglial activation at the injection
site from wild type and APP −/− mice are presented (Magnification x20; Scale bar = 200
µm). (e) A representative fluorescent micrograph identifying the injection site in a brain
section prepared from an APP −/− mouse co-injected with Mn2+ and rhodamine-dextran is
also presented (magnification x40 and scale bar = 200 µm).
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Figure 2. Hippocampal to forebrain axonal transport of Mn2+ is detectable at 7 hours post-
injection
(b) To aid visualization of Mn2+ transport following hippocampal injection a rendering of
the template brain surface with the hippocampus (green) and septal nuclei (blue) structures
identified is presented. Coronal MR slices from a representative wild type mouse, obtained 7
hours following injection, at the injection site (approx. −3.4 mm bregma) and in the
forebrain, at the position of the septal nuclei (approx. +0.4 mm bregma), demonstrate signal
increases due to Mn2+ transport from the injection site. (b) Representative and group
average MR axial images 7 hours following intra-hippocampal Mn2+ administration (scale
bar = 1 mm) are presented; visual assessment identifies a diffuse pattern of signal
enhancement within the injected hippocampus and an increase at the septal nuclei. (c) A
representative fluorescent micrographs of brain sections prepared from a representative APP
−/− mouse co-injected with Mn2+ and rhodamine-dextran demonstrate an increase in
fluorescence at the septal nuclei (magnification x40, scale bar = 200 µm). (d) and (e)
Representative micrographs of ChAT-stained brain sections, prepared from wild type and
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APP −/− mice, at the level of the septal nuclei, are presented (magnification x20; scale bar =
0.5 mm).
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Figure 3. Hippocampal to forebrain axonal transport of Mn2+ is reduced in APP −/− mice
Statistical parametric analysis illustrating the increase in signal enhancement due to Mn2+
transport at 7 hours in wild type (blue) and APP −/− (red) mice are presented. The statistical
parametric maps indicate changes at the dorsal hippocampal commissure (bregma −2.30
mm), ventral hippocampal commissure (−0.46 mm from midline) and the septal nuclei
(bregma +0.98 mm, +0.24 mm from midline). All statistical parametric maps are calculated
to p < 0.00001 (T = 7.09; n = 12).
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Figure 4. Contralateral Mn2+ transport is reduced in APP −/− mice at 25 hr post injection
(a) Representative and group average MR axial images 25 hours following intra-
hippocampal Mn2+ administration (scale bar = 1 mm); visual assessment identifies
continuing signal increase in the septal nuclei and an increase in the contralateral
hippocampus. (b) Statistical parametric maps illustrating the increase in signal enhancement
due to Mn2+ transport at 25 hours in wild type (blue) and APP −/− (red) mice are presented.
The statistical parametric maps indicate changes at the dorsal hippocampal commissure
(bregma −2.30 mm), ventral hippocampal commissure (bregma −0.46 mm) and the septal
nuclei (bregma +0.98 mm, +0.24 mm from midline). All statistical parametric maps are
calculated to p < 0.00001 (T = 7.09; n = 12).
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Figure 5. Contralateral Mn2+ and rhodamine-dextran transport to the contralateral
hippocampus is reduced in APP −/− mice
(a) and (b), representative fluorescent micrographs of brain sections prepared from wild type
and APP −/− mice co-injected with Mn2+ and rhodamine-dextran identify greater levels of
rhodamine-dextran present in the contralateral hippocampus (denoted by white arrowheads)
of wild type compared with APP −/− mice (magnification x40, scale bar = 200 µm). (c) The
statistical parametric increases exclusive to the hippocampus formation are presented within
semi-transparent renderings of the hippocampal structure for wild type and APP −/− mice.
All statistical parametric maps are calculated to p < 0.00001 (T = 7.09; n = 12).
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Figure 6. Representative and group average time-lapse coronal MR images demonstrate Mn2+
signal enhancement 25 hours after intra-ocular administration
(a) To aid visualization of Mn2+ transport following intra-ocular administration a rendering
of the template surface with the superior colliculus structure (green), lateral geniculate
(brown), internal optic tract (light purple), external optic tract (cyan) and eyeball (cyan)
identified is presented. A single coronal MR slice (approx. bregma −3.8 mm) from a
representative wild type mouse obtained 25 hours after injection demonstrates signal
increases in the superior colliculus due to Mn2+ transport along the optic tract. (b) and (c)
Representative and group average time-lapse MR coronal and axial images following intra-
ocular Mn2+ administration for both groups; images obtained prior to (pre) and 25 hours (25
hr) after Mn2+ administration are presented. Visual inspection identifies an increase in the
superior colliculus (denoted by arrows) at 25 hours due to transport of Mn2+ (Scale bar = 1
mm).
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Figure 7. Mn2+ transport in the visual system is reduced in APP −/− mice
Statistical parametric analysis illustrating the statistically significant signal increase 25 hours
after intra-ocular administration of Mn2+ in the structures along visual pathway for wild type
mice (blue) and APP −/− (red) are presented. Maps are overlaid onto saggital and coronal
images from the template (scale bar = 1 mm) to allow inspection of the changes at the lateral
geniculate nucleus and superior colliculus; saggital images are positioned from midline at
+2.40 mm and +0.44 mm respectively; coronal images are positioned at −2.30 mm and
−3.88 mm bregma respectively. All statistical parameter maps are calculated to p < 0.00001
(T = 7.09; n = 12).
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